Estrogen Receptor Antagonist [EPC]

40549 reported adverse events

Drugs of this class: FULVESTRANT ELACESTRANT IMLUNESTRANT

These side effects are most commonly reported by patients taking drugs of the Estrogen Receptor Antagonist [EPC] class:

# Side effect Count
0 FATIGUE 5334
1 NAUSEA 4565
2 MALIGNANT NEOPLASM PROGRESSION 4502
3 DEATH 3297
4 DIARRHOEA 3231
5 NEUTROPENIA 2553
6 WHITE BLOOD CELL COUNT DECREASED 2299
7 VOMITING 2288
8 METASTASES TO BONE 2233
9 NEOPLASM PROGRESSION 2208
See all common reactions for Estrogen Receptor Antagonist [EPC]

Drugs of the Estrogen Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PIK3CA-ACTIVATED MUTATION 167 0.5030
1 CARBOHYDRATE ANTIGEN 15-3 INCREASED 264 0.3469
2 TUMOUR MARKER INCREASED 900 0.1874
3 METASTASES TO PLEURA 173 0.1649
4 BREAST CANCER METASTATIC 1706 0.1587
5 METASTASES TO SKIN 163 0.1578
6 METASTASES TO BONE 2233 0.1359
7 METASTASES TO LIVER 1834 0.1042
8 BREAST CANCER RECURRENT 313 0.0990
9 METASTASES TO SPINE 330 0.0981
See all enriched reactions for Estrogen Receptor Antagonist [EPC]